Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

By Nqobile Dludla and Siyanda Mthethwa JOHANNESBURG (Reuters) -Danish drugmaker Novo Nordisk introduced its weight-loss drug ...

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

Weight-loss drugs like Mounjaro and Ozempic work wonders on your waistline but can cause chaos with your scalp. Here’s what ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

GLP-1 drugs, such as Ozempic and the combination drug tirzepatide also included in the study, mimic a natural hormone known as glucagon-like peptide-1 to help regulate blood sugar and insulin levels.